MedTrace Logo

Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection

NCT05176821 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2022-08-05

No results posted yet for this study

Summary

The aim of this study was to evaluate the efficacy and safety of high-dose dual therapy compared with furazolidone-based quadruple therapy as a rescue treatment for helicobacter pylori infection.

Conditions

  • H. Pylori Infection

Interventions

DRUG

esomeprazole plus amoxicillin

amoxicillin 750mg QID + esomeprazole 20mg QID for 14 days

DRUG

amoxicillin, furazolidone, bismuth potassium citrate , esomeprazole

amoxicillin 1000mg BID + furazolidone 100mg BID + bismuth potassium citrate 600mg BID + esomeprazole 20mg BID for 14 days

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Wei Jiang, MD · Xiamen branch of Zhongshan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05176821 on ClinicalTrials.gov